Background/Objective: Low birthweight (LBW) and intrauterine growth restriction are linked with maternal nutritional status during pregnancy, and maternal supplementation with multiple micronutrients (MMNs) is reported to increase birthweight. Responses to MMN, however, might be modified by maternal nutrition. Subjects/Methods: To examine the differential effects of maternal nutritional status on birthweight responses to prenatal MMN supplementation, data from the Supplementation with Multiple Micronutrient Intervention Trial, a cluster-randomized trial in Indonesia was analyzed. Birthweight outcomes of 7001 infants whose mothers received iron/folic acid were compared with 7292 infants whose mothers received MMN. The modifying effects of maternal short-term nutritional status (mid-upper arm circumference (MUAC) and long-term nutritional status (height) on the birthweight response to MMN supplementation were assessed. Results: For women with higher MUAC (X23.5 cm), MMN increased mean birthweight by 33 g (95% confidence interval (CI): À1 to 66, P ¼ 0.06) and significantly reduced LBW by 21% (relative risk: 0.79, 95% CI: 0.64-0.99, P ¼ 0.04). The modifying effect of MUAC on mean birthweight, LBW and small for gestational age was significant. There was no evidence of a modifying effect of maternal height on the response to MMN. Conclusions: Supplementation with MMN in pregnancy increased birthweight, but maternal nutritional status modified this response, with infants born to women with better short-term nutrition having greater birthweight response.
Introduction
Low birthweight (LBW), caused by either short gestation or fetal growth restriction or both, is closely associated with fetal and neonatal morbidity and death (Chard et al., 2001 , Yasmin et al., 2001 , Bartels et al., 2005 . Poor fetal growth, as measured by LBW and small for gestational age (SGA), is also linked with growth retardation and adult chronic diseases (Barker, 2007 , Bonamy et al., 2008 , Meas et al., 2008 , Pandolfi et al., 2008 . For girls, the lower their birthweight, the smaller their offspring will be at birth (Victora et al., 2008) . With the prevalence of LBW at 14% in Africa and 15% in southeast Asia (Bhutta and Haider, 2008) , attempts to reduce LBW are important for achieving the child survival Millennium Development Goals in low-income countries.
Links exist between maternal nutrition during pregnancy and birthweight. A meta-analysis found MMN reduced the risk of low birth weight by 17% (Shah and Ohlsson, 2009) compared with iron/folic acid (IFA), whereas another reported a 22.4 g increase in birthweight, an 11% reduction in LBW and 10% decrease in SGA (Fall et al., 2009) . The latter meta-analysis also reported effect modification of body mass index (BMI) at enrollment, showing that women with higher BMI delivered babies 39.0 g (95% confidence interval (CI): 22.0-56.1 g) heavier when given MMN compared with IFA, whereas women with lower BMI delivered babies 6.0 g (95% CI: À28.8 to 16.8 g) less.
Maternal mid-upper arm circumference (MUAC) is a more stable indicator of the nutritional status of pregnant women because it is independent of gestation (WHO, 1995) , yet it was not measured in most MMN trials. It was, however, measured in the Supplementation with Multiple Micronutrient Intervention Trial (SUMMIT) in Indonesia. Univariate subgroup analysis of SUMMIT data found a tendency of effect modification by MUAC, although not statistically significant. MMN was significantly associated with 37 g higher birthweight (95% CI: 1-72 g) and 18% lower risk of LBW (relative risk (RR): 0.82, 95% CI: 0.67-1.00) in women with a MUAC above and equal to 23.5 cm, whereas it had no effect in women with lower MUAC (SUMMIT Study Group, 2008) . However, these reported analyses were conducted on a restricted subgroup of women whose infants were weighed within 1 h of delivery (N ¼ 11 101). The objective of this paper is to examine the modifying effects of indicators of long-and short-term maternal nutritional status on the birthweight responses to MMN in pregnancy. It expands previous analyses by examining the modifying effect of maternal MUAC and height using a larger sample of newborns with birthweights measured within 72 h of delivery to increase statistical power.
Subjects and methods
Data for this study were taken from SUMMIT, a cluster randomized trial conducted on the island of Lombok, Indonesia, from 1 July 2001 to 1 April 2004. SUMMIT was registered as an International Standard Randomized Controlled Trial, number ISRCTN34151616. The SUMMIT study protocol was approved by the ethics committees in Indonesia and the United States of America (SUMMIT Study Group, 2008) .
The trial randomized midwives working in a population of approximately 2.7 million people to provide either IFA or MMN to pregnant women. Women who self-reported their pregnancy at any gestation to midwives had their pregnancy confirmed by a rapid urine test for human chorionic gonadotropin. Consenting women received through midwives 35 supplements of either IFA or MMN with the UN International Multiple Micronutrient Preparation formulation (Table 1) monthly to be taken once daily.
Socioeconomic information, anthropometry and pregnancy-related health data, including the date of the first day of the women's last menstrual period, were collected within 72 h of enrollment by maternal data collectors. Maternal data collectors were trained and had to pass all training modules, including anthropometric measurement, in order to be eligible for certification tests. They were certified and recertified to conduct anthropometric measurement according to SUMMIT data collection manuals that were in line with the World Health Organization guidelines.
MUAC was measured using a non-stretchable insertion tape, height using a microtoise (United Nations International Children's Emergency Fund no. 0114400 Height measuring instrument, 0-2 m) and weight using a Uniscale (United Nations International Children's Emergency Fund Supply Division, Copenhagen, Denmark). Scales were calibrated by maternal data collectors using a standardized weight everyday before the data collection. When the birth occurred maternal data collectors or a SUMMIT community facilitator visited and recorded the birth outcome. When possible, birthweight was recorded within 1 h of birth by a midwife, community facilitator or maternal data collector using a Uniscale or an infant digital scale (Tanita model BD585, Tanita Corporation, Tokyo, Japan or Seca model 334, Seca Corporation, Hamburg, Germany). A complete description of the SUMMIT trial methodology is reported elsewhere (SUMMIT Study Group, 2008) .
Live births were included in the analysis based on the following criteria: the infant was weighed within 72 h of birth with a Uniscale or an infant digital scale; and the measurement was collected by a trained SUMMIT staff member or midwife. Birthweights measured by traditional birth attendants showed marked heaping at increments of 500 g and were excluded from the analysis.
Nutritional status MUAC is used as an indicator of short-term maternal nutritional status. Unlike BMI, MUAC is independent of gestation, and it can be taken as a proxy of maternal weight before pregnancy or early gestational weight (WHO, 1995) . Maternal height at enrollment was the indicator of longterm nutritional status.
LBW was defined as birthweight o2500 g (WHO, 1994), and low nourished women were defined as women with MUAC p23.5 cm (SUMMIT Study Group, 2008) . Women were considered short when their height was o145 cm at enrollment (Ozaltin et al., 2010) . First trimester was from conception to the 14th completed week, second trimester was from the start of the 15th to the completion of the 28th week and third trimester was from the start of the 29th week to birth (WHO, 1994) . SGA was defined as birthweight below the 10th centile of the gestational age-sex specific United States reference for fetal growth (Alexander et al., 1996) .
Statistical analysis
Birthweight was normally distributed. The effect on mean birthweight was calculated and adjusted for cluster randomization by hierarchical linear regression models with SAS PROC MIXED with random intercept specification. The difference in birthweight response is presented with mean and 95% CIs. The RR and 95% CIs for LBW were estimated and adjusted for cluster randomization by SAS PROC GENMOD with log link function. We tested for interactions in the models between types of supplement and maternal nutritional status represented by MUAC and height. Results of subgroup analyses and the P-value for test of interaction are reported. For all tests, Po0.05 was considered significant except for test of interaction. The predefined criterion for significance of effect modifiers was Po0.10. We also report the results adjusted for the time after birth the weight was collected, twin status (yes/no), gestation at birth (weeks), age of woman (years), infant's sex (male/female), gestation at enrollment (weeks), wealth index (continuous), maternal height (tall/short) and MUAC (low/high). Owing to the high correlation between age of women and parity, parity was excluded from the adjusted analysis. Wealth index was obtained from principal component analysis of 12 household assets (Filmer and Pritchett, 1998) , which included the floor area of the house, ownership of bicycle, boat, car, horse cart, kiosk, refrigerator, vendor, house, motorbike, television set and radio. Because of the missing values, we also conducted unadjusted analyses in the restricted samples used in the adjusted analysis and compared the results with the unadjusted analysis for all observations with the complete data.
Results
As reported previously (SUMMIT Study Group, 2008) , out of 31 290 pregnancies followed up, 3.4% were lost to follow-up, 287 women dropped out of the study and 397 women moved out of the study area. There were 28 939 pregnancies with birth status. (Figure 1 ). There were 119 twins in the IFA and 134 in the MMN group. The inclusion criteria in this study resulted in a selection of births from women who were generally better educated, and with slightly better health status, than those not included. Around 14.4% of women excluded had no formal education and 51.5% had some primary education compared with only 9.3% without formal education and 46.7% with only primary education for those included in the analysis. Of the women not selected, 31.7% in the IFA and 31.1% in the MMN groups had MUAC o23.5 cm compared with only 27.7 and 28.7% in the IFA and the MMN, respectively, in selected women. Women selected for the analysis had a slightly lower percentage of child deaths before the study, with 16.2 and 16.0% reporting at least one child dead in both the IFA and the MMN groups, respectively, compared with 21.0 and 20.3% in the IFA and the MMN groups, respectively, amongst women not included. The households of women included in the analysis had a higher proportion owning motorbikes, televisions and radios, thus, indicating slightly higher socioeconomic status compared with women not included.
The baseline characteristics of age, pregnancy history, education, socioeconomic status and nutritional status of women included in the study were similar for the IFA and MMN groups (Table 2) . We also examined the baseline characteristics between IFA and MMN group in the subgroups of women with high MUAC and low MUAC as well as subgroups of short and tall women. We found that baseline characteristics were similar between IFA and MMN group in all subgroups of women (data not shown).
The correlation between BMI and height and between height and MUAC were low (r ¼ À0.007 and r ¼ 0.16), whereas correlation between BMI and MUAC was moderate (r ¼ 0.76). The correlation coefficient between BMI and MUAC were higher in women enrolling in the first trimester (r ¼ 0.83), whereas correlations between BMI and height and MUAC remained small (r ¼ À0.01 and r ¼ 0.14, respectively). All correlations were similar between the IFA and MMN group.
Around 13% of the women did not have MUAC measurement. A total of 48% in IFA and 42.6% in the MMN group of women enrolling at third trimester had missing MUAC measurement compared with only B4 and 2% in women enrolling at second and first trimester. However, the missing values were balanced between the treatment groups. There was around 6% missing value in maternal height that spread randomly in all trimester of enrollment. Therefore, the missing values in anthropometric measurements will not affect the results. As shown in Table 3 , there was a slight increase of 15 g in mean birthweight of babies born to mothers who received MMN. The mean birthweight difference increased to 19 g (95% CI: À12 to 50, P ¼ 0.23) for MMN compared with IFA after adjusting for the time birthweight was measured, twin status, gestation at birth, age of woman, infant's sex, gestation at enrollment, wealth index, maternal height, MUAC and BMI.
The effect of MMN on mean birthweight was modified by MUAC, with infants born to women with larger arm circumference benefiting more than those born to women with lower MUAC (P-value for interaction ¼ 0.06). After adjustment, the modifying effect of MUAC became more significant (33 g compared to À10 g, P-value for interaction ¼ 0.02). Using MUAC as a continuous variable, the effect of MMN increased birthweight by 0.3 g (95% CI: À0.4 to 0.9) more than IFA with each millimeter increase in maternal MUAC after adjustment for confounders. There was no evidence of a modified benefit of MMN on mean birthweight by maternal height. 
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The proportion of LBW in the study population was 5.8%. MMN tended to reduce the risk of LBW by 12% (RR: 0.88, 95% CI: 0.75-1.03, P ¼ 0.10) compared with IFA. This effect estimate did not change much after controlling for confounders (Table 4) . Similar to the mean birthweight response, the effect of MMN on LBW tended to be modified by MUAC (P for interaction ¼ 0.15) and the modifying effect was significant after adjustment for other factors (P for interaction ¼ 0.04). If anything, there was a very weak tendency that when given MMN, shorter woman had lower risk of delivering LBW babies compared with taller women.
The proportion of SGA was 15.5%. Overall, MMN did not have any effect on SGA. The RRs for SGA was 0.98 (95% CI: 0.88-1.09, P ¼ 0.71) and adjusting for confounders resulted in a nonsignificant 4% reduction of SGA (RR ¼ 0.96, 95% CI: 0.85-1.07, P ¼ 0.44). However, the modifying effect of MUAC was significant for this outcome and with the same direction found for the effect on mean birthweight and LBW (P for interaction ¼ 0.05). We found no modifying effect of height on SGA response to MMN (Table 4) .
The median compliance was 84.8% in IFA group and 83.3% in MMN group as assessed by pill counts at the home and at the integrated health post. Adding mean compliance in the adjusted analysis of all outcomes resulted in similar RRs and CIs. By doing this addition, however, only 78% of the total observation was included in the adjusted analysis. Therefore, we did not include compliance in the final analysis.
We did an unadjusted analysis using the restricted cohort included in the adjusted analysis to assess the effect of missing values. We found the results of the unadjusted analysis in the total cohort and the restricted cohort were very similar for all outcomes. We also found similar results when twin births were excluded from all analysis (data not shown).
Discussion
This paper highlights the modifying effect of maternal MUAC and height, which have not been reported in other MMN supplementation trials. Other studies have reported a modifying effect of maternal BMI at enrollment (Osrin et al., 2005 , Roberfroid et al., 2008 . However, maternal BMI during pregnancy is dependent on gestation. We believe that MUAC at enrollment is a better indicator for assessing the modifying effect of maternal nutritional status on birthweight response to MMN.
There was an attenuation of the birthweight response to MMN by increasing the sample size to include those weighed within 72 h of birth. Analyses of newborns from mothers receiving MMN and weighed within 1 h of delivery showed a 21 g increase in birthweight (SUMMIT Study Group, 2008), whereas we found a 15 g increase.
The impact of MMN on birthweight was modified by MUAC. Women with higher MUAC or better short-term Abbreviations: IFA, iron folic acid; LBW, low birthweight; MMN, multiple micronutrients; SGA, small for gestational age.
a Adjusted for weighing time, twin status, gestation at birth, age of woman, infant's sex, gestation at enrollment, wealth index, mid-upper arm circumference, and maternal height.
nutritional status had a greater increase in birthweight and significant reduction in LBW compared with women with lower MUAC or poorer short-term nutritional status. Shorter women or those with evidence of long-term previous malnutrition, who were treated with MMN, had a greater increase in birthweight and reduction in LBW than taller women, but these findings were not significant. Our results indicate that the short-term nutritional status of women does modify the birthweight response to supplementation with MMN, but with an unexpected pattern of greater response in better-nourished women. Meanwhile, there is not enough evidence to show that birthweight response to MMN was modified by long-term nutritional status. The modifying effect of MUAC suggests that the current dose of micronutrients in MMN supplements may be insufficient to improve infant birthweight for women who are depleted of micronutrients. Interactions between micronutrients, especially between iron, zinc and copper (Arredondo et al., 2006) , may have lessened the actual impact of MMN. This study used MMN with the UN International Multiple Micronutrient Preparation formulation of only one recommended dietary allowance of the micronutrients and compared it with IFA. A study from Guinea Bissau, which examined the effects of a single and double dose of MMN supplements with the UN International Multiple Micronutrient Preparation formulation, reported that doubling the dose of all micronutrients other than iron improved the birthweight response in their study population (Kaestel et al., 2005) . The trial in Tanzania that used much higher doses of vitamin E and B, but removed vitamin A and zinc, reported a response similar to what we found in Indonesia (Fawzi et al., 2007) . In China, comparing the UN International Multiple Micronutrient Preparation formulation with the standard dose of IFA, which is twice as much as in our study resulted in a mean birthweight increase similar to our findings, but there was little difference found in the LBW response (Zeng et al., 2008) . Interestingly, a study in Burkina Faso (Roberfroid et al., 2008) and in Indonesia (Sunawang et al., 2009 ) that studied similar comparison reported a slightly greater increase in birthweight and a similar reduction in LBW compared with our results.
It is possible that a critical supply of macronutrients is required to ensure a birthweight response to MMN. Better-nourished women may have enough fat and protein intake to help metabolize fat soluble vitamins and transport minerals. Vitamin E, for example, is absorbed in the intestine together with lipids (Brigelius-Flohe and Traber, 1999) and needs the a-tocopherol transfer protein to transport tocopherol from liver to plasma (Traber and Traber, 2007) . Supplementation of vitamin E in healthy individuals has been reported to result in higher plasma concentrations of a-tocopherol when combined with high fat diets (Dimitrov et al., 1991) .
There is evidence of an association between maternal nutrition, placental development and birthweight. Both placental weight and birthweight were reduced with increasing carbohydrate intake in early pregnancy or with a low intake of animal protein later in gestation (Godfrey et al., 1996) . The heavier the mother before pregnancy (Kinare et al., 2000) or the higher the BMI in early pregnancy, the greater the placenta volume and birthweight (Thame et al., 2004) . Placenta weight and birthweights have also been reported to be lower in shorter women (Godfrey et al., 1996) . Better-developed placentas of well-nourished women may enable a greater transfer of MMN to the fetus and explain the larger effect of MMN in these women. Similar findings have been reported from a trial in Nepal (Danusha) (Osrin et al., 2005) and Burkina Faso (Roberfroid et al., 2008) , where women with higher BMI had a larger birthweight response to MMN compared with those with low BMI. Our results were unexpectedly different from the unadjusted impact of MMN on infant mortality, in which there was a greater mortality sparing effect in malnourished women (SUMMIT Study Group, 2008) . This finding may indicate that reduced risk of mortality can take place without a significant increase in birthweight or reduction of LBW. However, an adjusted analysis of the impact of MMN on infant mortality is needed to confirm this paradox.
Arguably, using the date of last menstrual period might underestimate the gestation of our population because of recall bias. This underestimation would occur in both treatment arms because of the randomization and, therefore, we found weak associations in both groups for the SGA outcome. Adjustment with gestation at enrollment and at birth in the analysis, however, did not result in meaningful changes in the point estimates.
The selection criteria for our birthweight analysis has restricted the study cohort to slightly more educated, betternourished women from a higher socioeconomic status. They were more likely to have had their delivery attended by a trained professional and to have given birth in a facility. Our results, therefore, might overestimate the effects of MMN supplementation in the general population.
A potential bias may have been introduced into the analyses, as some women were not included in the stratified analysis because they lacked information on the potential effect modifiers-MUAC or height. Baseline characters of women with missing MUAC were similar to those of women with complete observations except for the fact that they mostly enrolled in the third trimester. However, the missing values were balanced in both treatment arms. Because of the missing values, our adjusted analysis included only around 80% of the data. The missing observations, however, did not affect our results.
Future research should examine the impact of larger doses of MMNs on birthweight. To find the optimum dose of MMN for birthweight and mortality responses, other studies are needed to examine the effect of giving more than one recommended dietary allowance of MMN. Research to assess the impact of combining MMN with macronutrient supplementation would also be beneficial in understanding the impact of MMN on birthweight.
